OneAscent Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,395
Closed -$208K 631
2026
Q1
$208K Buy
+2,395
New +$229K 0.01% 557
2025
Q4
Sell
-2,611
Closed -$249K 514
2025
Q3
$249K Sell
2,611
-1,139
-30% -$105K 0.02% 421
2025
Q2
$332K Sell
3,750
-22
-0.6% -$1.87K 0.02% 388
2025
Q1
$337K Buy
3,772
+175
+5% +$15.7K 0.02% 395
2024
Q4
$287K Buy
3,597
+527
+17% +$45.6K 0.02% 368
2024
Q3
$279K Buy
3,070
+410
+15% +$34.5K 0.2% 134
2024
Q2
$209K Buy
2,660
+292
+12% +$23.9K 0.03% 233
2024
Q1
$206K Sell
2,368
-67
-3% -$5.72K 0.02% 362
2023
Q4
$201K Buy
+2,435
New +$186K 0.02% 352
2021
Q1
$229K Buy
1,942
+151
+8% +$17.7K 0.23% 120
2020
Q4
$211K Sell
1,791
-2,403
-57% -$265K 0.23% 109
2020
Q3
$436K Buy
4,194
+44
+1% +$4.42K 0.23% 87
2020
Q2
$381K Buy
4,150
+365
+10% +$35K 0.25% 82
2020
Q1
$341K Buy
3,785
+252
+7% +$26.8K 0.26% 66
2019
Q4
$401K Buy
+3,533
New +$388K 0.22% 80
2019
Q3
Sell
-4,375
Closed -$426K 118
2019
Q2
$426K Buy
+4,375
New +$399K 0.29% 66

Other funds holding MDT

OneAscent Financial Services's MDT Position: Q2 2026 in Review

OneAscent Financial Services sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,395 shares — an estimated $208K sold.

OneAscent Financial Services first reported a position in MDT in Q2 2019 and held it in 16 quarters. The position peaked at $436K in Q3 2020. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • OneAscent Financial Services reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • OneAscent Financial Services sold 2,395 Medtronic shares in Q2 2026, an estimated $208K.
  • OneAscent Financial Services first reported a position in Medtronic in Q2 2019 and held it in 16 quarters.
  • OneAscent Financial Services's Medtronic position peaked at $436K in Q3 2020.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.